1. Home
  2. BLDE vs MRVI Comparison

BLDE vs MRVI Comparison

Compare BLDE & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • MRVI
  • Stock Information
  • Founded
  • BLDE 2014
  • MRVI 2014
  • Country
  • BLDE United States
  • MRVI United States
  • Employees
  • BLDE N/A
  • MRVI N/A
  • Industry
  • BLDE Aerospace
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLDE Consumer Discretionary
  • MRVI Health Care
  • Exchange
  • BLDE Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • BLDE 285.2M
  • MRVI 312.4M
  • IPO Year
  • BLDE N/A
  • MRVI 2020
  • Fundamental
  • Price
  • BLDE $4.27
  • MRVI $2.43
  • Analyst Decision
  • BLDE Strong Buy
  • MRVI Hold
  • Analyst Count
  • BLDE 2
  • MRVI 10
  • Target Price
  • BLDE $6.25
  • MRVI $6.84
  • AVG Volume (30 Days)
  • BLDE 739.9K
  • MRVI 2.0M
  • Earning Date
  • BLDE 08-06-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • BLDE N/A
  • MRVI N/A
  • EPS Growth
  • BLDE N/A
  • MRVI N/A
  • EPS
  • BLDE N/A
  • MRVI N/A
  • Revenue
  • BLDE $251,485,000.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • BLDE $5.79
  • MRVI N/A
  • Revenue Next Year
  • BLDE $8.35
  • MRVI $10.91
  • P/E Ratio
  • BLDE N/A
  • MRVI N/A
  • Revenue Growth
  • BLDE 8.67
  • MRVI N/A
  • 52 Week Low
  • BLDE $2.35
  • MRVI $1.67
  • 52 Week High
  • BLDE $5.17
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 61.55
  • MRVI 48.03
  • Support Level
  • BLDE $4.02
  • MRVI $2.52
  • Resistance Level
  • BLDE $4.65
  • MRVI $2.93
  • Average True Range (ATR)
  • BLDE 0.19
  • MRVI 0.18
  • MACD
  • BLDE 0.01
  • MRVI -0.03
  • Stochastic Oscillator
  • BLDE 60.99
  • MRVI 18.03

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: